tolvaptan has been researched along with digoxin in 3 studies
Studies (tolvaptan) | Trials (tolvaptan) | Recent Studies (post-2010) (tolvaptan) | Studies (digoxin) | Trials (digoxin) | Recent Studies (post-2010) (digoxin) |
---|---|---|---|---|---|
967 | 172 | 786 | 11,483 | 958 | 1,289 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bricmont, P; Furukawa, M; Kashiyama, E; Mallikaarjun, S; Ninomiya, S; Ohzone, Y; Shoaf, SE | 1 |
Butler, J; Gheorghiade, M; Greene, SJ; Harinstein, ME; Konstam, MA; Maggioni, AP; Subačius, H; Swedberg, K; Vaduganathan, M; Zannad, F | 1 |
1 review(s) available for tolvaptan and digoxin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for tolvaptan and digoxin
Article | Year |
---|---|
In vitro P-glycoprotein interactions and steady-state pharmacokinetic interactions between tolvaptan and digoxin in healthy subjects.
Topics: Administration, Oral; Adolescent; Adult; Analysis of Variance; Animals; Antidiuretic Hormone Receptor Antagonists; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzazepines; Cardiotonic Agents; Digoxin; Drug Administration Schedule; Drug Interactions; Female; Florida; Hormone Antagonists; Humans; LLC-PK1 Cells; Male; Metabolic Clearance Rate; Models, Biological; Swine; Tolvaptan; Transfection; Young Adult | 2011 |
Prognostic value of monocyte count in patients hospitalized for heart failure with reduced ejection fraction (from the EVEREST Trial).
Topics: Angiotensin-Converting Enzyme Inhibitors; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cardiotonic Agents; Digoxin; Double-Blind Method; Follow-Up Studies; Heart Failure; Hospital Mortality; Humans; Inpatients; Kaplan-Meier Estimate; Leukocyte Count; Monocytes; Prognosis; Prospective Studies; Stroke Volume; Survival Rate; Tolvaptan | 2012 |